Illumina: What Is Next In This Sequence?
Source: SeekingAlpha
2026-01-20 01:27:32 ET
In the spring of 2023, I wondered what was up with the genes in the case of Illumina (ILMN) as the company suffered issues around its GRAIL (GRAL) acquisition. This uncertainty caused interest from activist investor Carl Icahn, looking to stir up things....
Read the full article on Seeking Alpha
For further details see:
Illumina: What Is Next In This Sequence?
Illumina Inc.
NASDAQ: ILMN
ILMN Trading
0.93% G/L:
$119.365 Last:
761,771 Volume:
$116.10 Open:
ILMN Latest News
March 05, 2026 09:15:00 am
Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering
February 27, 2026 09:15:00 am
Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida
February 25, 2026 09:15:00 am
Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics
February 24, 2026 12:15:00 pm
Illumina launches TruPath Genome, setting a new standard in genomic insight
ILMN Stock Data
$18,085,408,000
148,827,200
0.13%
404
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
